Aromatase inhibitors declared superior to tamoxifen in the adjuvant treatment of early breast cancer

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2006年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1104 / 1105
页数：2
相关论文
共 50 条
  • [31] Quality of Life of Women With Breast Cancer Treated in Adjuvant Setting With Tamoxifen or Aromatase Inhibitors
    Volovat, S.
    Apostol, D.
    Volovat, C.
    Carausu, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S379 - S379
  • [32] Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
    Eggemann, Holm
    Ignatov, Atanas
    Smith, Bobbie J.
    Altmann, Udo
    von Minckwitz, Gunter
    Roehl, Freidrich W.
    Jahn, Mark
    Costa, Serban-Dan
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 465 - 470
  • [33] Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
    Holm Eggemann
    Atanas Ignatov
    Bobbie J. Smith
    Udo Altmann
    Gunter von Minckwitz
    Freidrich W. Röhl
    Mark Jahn
    Serban-Dan Costa
    [J]. Breast Cancer Research and Treatment, 2013, 137 : 465 - 470
  • [34] RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
    Klar, Natalie
    Adams, Sylvia
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (01) : 165 - 166
  • [35] Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
    Van Poznak, Catherine H.
    Hayes, Daniel F.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (18) : 1261 - 1263
  • [36] ASSESMENT OF QUALITY OF LIFE OF THE ADJUVANT TREATMENT WITH TAMOXIFEN VERSUS AROMATASE INHIBITORS AT WOMEN WITH BREAST CANCER - A RANDOMIZED TRIAL
    Volovat, C.
    Volovat, Simona Ruxandra
    Dogaru, C.
    Vulpoi, Carmen
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2011, 115 (01): : 53 - 57
  • [37] Aromatase inhibitors in the treatment of early and advanced breast cancer
    Joensuu, H
    Ejlertsen, B
    Lonning, PE
    Rutqvist, LE
    [J]. ACTA ONCOLOGICA, 2005, 44 (01) : 23 - 31
  • [38] Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: Aromatase inhibitors versus tamoxifen
    Carpenter, R.
    [J]. EJSO, 2008, 34 (07): : 746 - 755
  • [39] Treatment persistence evaluation of tamoxifen and aromatase inhibitors in breast cancer patients in early and late stage disease
    Schmidt, Nina
    Kostev, Karel
    Jockwig, Achim
    Kyvernitakis, Lannis
    Albert, Ute-Susann
    Hadji, Peyman
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (11) : 933 - 939
  • [40] Aromatase inhibitors in adjuvant setting in breast cancer
    Spano, JP
    Khayat, D
    Delozier, T
    [J]. BULLETIN DU CANCER, 2004, 91 : S239 - S243
12345